PSAP-基因组区域:一种利用人口数据的方法,在全基因组测序中优先考虑编码和非编码变体,用于罕见疾病诊断
Marie-Sophie C Ogloblinsky1, Ozvan Bocher1,2, Chaker Aloui3
1Univ Brest, Inserm, EFS, UMR 1078, GGB, Brest, France.
Genetic epidemiology
|September 25, 2024
概括
一种新的方法,PSAP-基因组区域,通过优先考虑整个基因组的遗传变异来增强罕见疾病诊断. 该工具显著改善了变体排名,有助于识别未被诊断的遗传疾病的原因.
科学领域:
- 基因组学就是基因组学.
- 医学遗传学 医学遗传学
背景情况:
- 下一代测序 (NGS) 已经推进了罕见疾病诊断,但超过一半的病例仍未被诊断出来,特别是在异质或罕见的疾病中.
- 目前的变异优先级方法有限,特别是对于非编码变异,阻碍了复杂遗传疾病的分子诊断.
研究的目的:
- 将人口采样概率 (PSAP) 方法扩展到非编码基因组,创建PSAP基因组区域以优先考虑全基因组变异.
- 通过有效排序编码和非编码变体来提高罕见和未诊断疾病的诊断产量.
主要方法:
- 开发了PSAP基因组区域,利用功能上受限制的基因组区域作为测试单元而不是基因.
- 使用模拟的外体和基因组数据集评估了该方法,其中包含来自ClinVar.Var的已知致病变体.
- 将PSAP基因区域应用于脑小血管疾病和男性不孕症患者的真实测序数据.
主要成果:
- 在排名变异中,PSAP基因组区域显著超过了单独的病原性得分.
- 超过50%的非编码的ClinVar变异在使用PSAP基因组区域的前10名中排名.
- 所有测试患者的因果变异 (大脑小血管疾病和男性不孕症) 在前100种变异中被确定.
结论:
- PSAP-基因组区域是一个有效的全基因组变异优先级工具,包含非编码区域.
- 该方法通过改善病原体变异的识别,为诊断未解决的罕见疾病提供了希望.
相关概念视频
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
Gene Evolution - Fast or Slow?
7.0K
The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
In contrast, regions which code...
7.0K
Comparing Copy Number Variations and SNPs
17.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.6K
Single Nucleotide Polymorphisms-SNPs
14.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.8K


